Description
Entekor- 0.5 (90 Tablets)
Composition: Entacavir 0.5mg
Therapeutic class: Hepatitis B medicine
Entekor: Doctor-Recommended Solution for Hepatitis B
Entekor is a trusted Hepatitis B treatment, prescribed by doctors and used by patients in over 50 countries. Renowned for its quality, affordability, and therapeutic reliability, Entekor is a preferred brand for long-term Hepatitis B management worldwide.
Aprazer Healthcare: Advancing Global Hepatology Care
Aprazer Healthcare stands at the forefront of hepatology innovation, manufacturing high-quality, world-standard medicines.
- ✔ WHO-GMP Certified
- ✔ Proven Therapeutic Efficacy & Safety
- ✔ Global Reach with Affordable Access
We supply all WHO-listed essential hepatitis medicines across the globe, making advanced liver care accessible and affordable for all.
What is Entekor?
Entekor is a Hepatitis B medicine, which mimics the DNA bases and inhibits its replication.
How does Entekor work?
It gets incorporated into viral DNA, inhibiting DNA polymerase, and stops viral chain elongation and cell multiplication.
Uses of Entekor
- • Chronic Hepatitis B
- • Prophylactic treatment for Hepatitis B
- • To prevent the Reactivation of HBV
Benefits
- • Reduces viral load
- • Improves liver functions
- • It can be used in both compensated and decompensated liver disease
Common Side Effects
- • Nausea
- • Dizziness
- • Headache
- • Digestive issues
- • Tiredness
- • • • Diarrhea
Serious Side Effects
- • Lactic Acidosis – unusual pain, breathing issues, irregular heartbeats, abdominal pain
- • Irregular heartbeat
- • Trouble breathing
Precautions
To be used cautiously in patients with:
- • Kidney disorders
- • HIV –co-infections
- • Liver transplant
Contraindications
- • Not to be used if any previous allergy or hypersensitivity to Entacavir or any excipients.
- • Breastfeeding mothers
- • Pregnant women
Warning
To be used under medical prescription only
Important Safety and Monitoring Information
- • Liver function
- • Renal function
- • Bone density
- • Viral load and co-HIV infections
